PTAB challenges

Proceedings overview

As of May 29, 2026, there are no AIA trial proceedings on file for US Patent 9,235,259. This means the patent has not been subjected to Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) proceedings at the USPTO's Patent Trial and Appeal Board (PTAB). This lack of PTAB activity suggests that all claims of the patent remain untested and are currently presumed valid. For a defendant, this means there are no prior PTAB decisions to leverage for invalidity arguments, and any defensive posture would need to initiate a new PTAB challenge or rely on district court litigation.

Strategic summary

Currently, all claims of US 9,235,259 are untested by PTAB proceedings. No claims have been canceled or sustained through an AIA trial. Consequently, there is no estoppel landscape established under § 315(e)(2), meaning a potential petitioner would not be barred from raising any prior-art grounds that they raised or reasonably could have raised in a prior IPR. There are no pattern signals of multiple IPR filings by the same petitioner or aggressive PTAB appeals by the patent owner, nor is a defensive aggregator involved in any PTAB proceedings for this patent.

Recommended next steps

Since no PTAB activity exists for US Patent 9,235,259, a defendant facing assertion of this patent should consider initiating an AIA trial proceeding (e.g., IPR) if viable prior art can be identified. The absence of prior PTAB challenges might indicate that potential petitioners have not yet found sufficiently strong prior art to warrant a challenge, or it could simply mean the patent has not been asserted widely enough to attract such challenges.